Proton Therapy Hypofractionation for Prostate CancerAn effective option that reduces the length of radiation treatment in a young patient with early-stage prostate cancer
An effective option that reduces the length of radiation treatment in a young patient with early-stage prostate cancer
Dana-Farber Cancer Institute Faculty Recognized as 2021 ASCO Leaders in Cancer Care
Critical Care Protocols and Teamwork Help Emory Kidney Transplant Program Meet Pandemic-Related Challenges
CD40 Drug Before Surgery Shows Promise in Early-stage Pancreatic Cancer
Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells
Dana-Farber Research Leads to Better Understanding of the Immune System in Kidney Cancer
Department Receives $4 Million Gift to Support Prostate Health
Research Initiatives Include Two New Grants from the National Institutes of Health
Mount Sinai Holds Prostate Cancer Research Stay at Home Gala to Showcase Research Priorities
COVID-19 Research: Differences in Infection Rates for Men and Women and a Potential Link to Prostate Cancer
Immunotherapy Combination Improves Outcomes in Advanced Kidney Cancer
Two Leading Organizations Come Together for Better Cancer Care
Roswell Park Researchers Identify New Biomarker of Response to Checkpoint Inhibitors
Innovating Care for Patients with Thoracic Cancers
A More Comprehensive, Patient-Centered Approach to Staghorn Calculi
Showing 136 - 150 of 447 results
Previous| 1... 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 ...30 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account